• 1. Establishing new scaling relations on two-dimensional MXenes for CO2 electroreduction?
  Albertus D. Handoko,Khoong Hong Khoo,Teck Leong Tan,Hongmei Jin,Zhi Wei Seh J. Mater. Chem. A, 2018,6, 21885-21890
• 2. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544
• 3. Evidence of field induced slow magnetic relaxation in cis-[Co(hfac)2(H2O)2] exhibiting tri-axial anisotropy with a negative axial component?
  Denis V. Korchagin,Elena A. Yureva,Alexander V. Akimov,Eugenii Ya. Misochko,Gennady V. Shilov,Artem D. Talantsev,Roman B. Morgunov,Alexander A. Shakin,Sergey M. Aldoshin,Boris S. Tsukerblat Dalton Trans., 2017,46, 7540-7548
• 4. Exceptional activity of sub-nm Pt clusters on CdS for photocatalytic hydrogen production: a combined experimental and first-principles study?
  Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064
• 5. Excess electrons in lithium–ethylamine solutions—density, electrical conductivity and EPR studies
  Phys. Chem. Chem. Phys., 1999,1, 3561-3565

5-(Pyrimidin-5-yl)nicotinaldehyde: A Comprehensive Overview

5-(Pyrimidin-5-yl)nicotinaldehyde, also known by its CAS number 1346687-35-1, is a compound of significant interest in the fields of organic chemistry and pharmacology. This molecule is characterized by its unique structure, which combines a pyrimidine ring with a nicotinaldehyde moiety. The pyrimidine ring, a six-membered aromatic structure with two nitrogen atoms, is a common feature in many biologically active compounds, including nucleosides and certain anticancer agents. The nicotinaldehyde group, on the other hand, adds a reactive aldehyde functionality, making this compound versatile for various chemical modifications and biological applications.

The synthesis of 5-(Pyrimidin-5-yl)nicotinaldehyde typically involves multi-step organic reactions, often utilizing palladium-catalyzed coupling reactions or other advanced methodologies. Recent advancements in catalytic asymmetric synthesis have enabled the preparation of enantiomerically pure derivatives, which are invaluable for studying stereochemical effects in biological systems. Researchers have also explored green chemistry approaches to enhance the sustainability of its production, aligning with global efforts to reduce environmental impact in chemical manufacturing.

In terms of biological activity, 5-(Pyrimidin-5-yl)nicotinaldehyde has shown promise as a potential lead compound in drug discovery. Studies have demonstrated its ability to modulate key enzymes and signaling pathways involved in diseases such as cancer and inflammation. For instance, it has been reported to inhibit certain kinases that play critical roles in tumor progression. Additionally, its aldehyde group can undergo various bioconjugation reactions, enabling the creation of bioactive molecules with enhanced targeting capabilities.

The structural versatility of 5-(Pyrimidin-5-yl)nicotinaldehyde has led to its use as a building block in medicinal chemistry. By modifying the pyrimidine or nicotinaldehyde moieties, researchers can generate a wide array of derivatives with diverse biological profiles. Recent research has focused on optimizing its pharmacokinetic properties, such as improving bioavailability and reducing toxicity, which are essential for translating laboratory findings into clinical applications.

The application of computational chemistry tools has significantly accelerated the study of 5-(Pyrimidin-5-yl)nicotinaldehyde. Molecular docking studies have provided insights into its binding modes with target proteins, while quantum mechanical calculations have elucidated its electronic properties. These computational approaches complement experimental studies, offering a holistic understanding of the compound's behavior at the molecular level.

In conclusion, 5-(Pyrimidin-5-yl)nicotinaldehyde, CAS number 1346687-35-1, represents a valuable compound in contemporary chemical research. Its unique structure, coupled with recent advances in synthesis and biological evaluation, positions it as a promising candidate for future drug development. As research continues to uncover its full potential, this compound will undoubtedly contribute to the advancement of therapeutic interventions across various disease states.

• 198084-12-7(4-(pyrimidin-5-yl)benzaldehyde)
• 229008-16-6(5-(4-Methylphenyl)-3-pyridinecarbaldehyde)
• 640769-71-7(2-(Pyrimidin-5-yl)benzaldehyde)
• 131231-24-8(3-(Pyridin-3-yl)benzaldehyde)
• 171820-00-1(4,4'-(3,5-Pyridinediyl)bisbenzaldehyde)
• 113118-84-6(5-Phenylnicotinaldehyde)
• 887973-66-2(5-(3-methylphenyl)pyridine-3-carbaldehyde)
• 640769-70-6(3-(pyrimidin-5-yl)benzaldehyde)
• 127406-55-7(4-(Pyridin-3-yl)benzaldehyde)
• 73082-69-6(5-(Pyridin-3-yl)pyrimidine)